467 related articles for article (PubMed ID: 30699315)
1. Oral versus Intravenous Antibiotics for Bone and Joint Infection.
Li HK; Rombach I; Zambellas R; Walker AS; McNally MA; Atkins BL; Lipsky BA; Hughes HC; Bose D; Kümin M; Scarborough C; Matthews PC; Brent AJ; Lomas J; Gundle R; Rogers M; Taylor A; Angus B; Byren I; Berendt AR; Warren S; Fitzgerald FE; Mack DJF; Hopkins S; Folb J; Reynolds HE; Moore E; Marshall J; Jenkins N; Moran CE; Woodhouse AF; Stafford S; Seaton RA; Vallance C; Hemsley CJ; Bisnauthsing K; Sandoe JAT; Aggarwal I; Ellis SC; Bunn DJ; Sutherland RK; Barlow G; Cooper C; Geue C; McMeekin N; Briggs AH; Sendi P; Khatamzas E; Wangrangsimakul T; Wong THN; Barrett LK; Alvand A; Old CF; Bostock J; Paul J; Cooke G; Thwaites GE; Bejon P; Scarborough M;
N Engl J Med; 2019 Jan; 380(5):425-436. PubMed ID: 30699315
[TBL] [Abstract][Full Text] [Related]
2. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
[TBL] [Abstract][Full Text] [Related]
3. Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial.
Li HK; Scarborough M; Zambellas R; Cooper C; Rombach I; Walker AS; Lipsky BA; Briggs A; Seaton A; Atkins B; Woodhouse A; Berendt A; Byren I; Angus B; Pandit H; Stubbs D; McNally M; Thwaites G; Bejon P
Trials; 2015 Dec; 16():583. PubMed ID: 26690812
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection.
Bernard L; Arvieux C; Brunschweiler B; Touchais S; Ansart S; Bru JP; Oziol E; Boeri C; Gras G; Druon J; Rosset P; Senneville E; Bentayeb H; Bouhour D; Le Moal G; Michon J; Aumaître H; Forestier E; Laffosse JM; Begué T; Chirouze C; Dauchy FA; Devaud E; Martha B; Burgot D; Boutoille D; Stindel E; Dinh A; Bemer P; Giraudeau B; Issartel B; Caille A
N Engl J Med; 2021 May; 384(21):1991-2001. PubMed ID: 34042388
[TBL] [Abstract][Full Text] [Related]
5. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis.
Iversen K; Ihlemann N; Gill SU; Madsen T; Elming H; Jensen KT; Bruun NE; Høfsten DE; Fursted K; Christensen JJ; Schultz M; Klein CF; Fosbøll EL; Rosenvinge F; Schønheyder HC; Køber L; Torp-Pedersen C; Helweg-Larsen J; Tønder N; Moser C; Bundgaard H
N Engl J Med; 2019 Jan; 380(5):415-424. PubMed ID: 30152252
[TBL] [Abstract][Full Text] [Related]
6. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
Hewer SCL; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Williamson PR;
Lancet Respir Med; 2020 Oct; 8(10):975-986. PubMed ID: 33007285
[TBL] [Abstract][Full Text] [Related]
7. Omadacycline for Acute Bacterial Skin and Skin-Structure Infections.
O'Riordan W; Green S; Overcash JS; Puljiz I; Metallidis S; Gardovskis J; Garrity-Ryan L; Das AF; Tzanis E; Eckburg PB; Manley A; Villano SA; Steenbergen JN; Loh E
N Engl J Med; 2019 Feb; 380(6):528-538. PubMed ID: 30726689
[TBL] [Abstract][Full Text] [Related]
8. Single-dose oritavancin in the treatment of acute bacterial skin infections.
Corey GR; Kabler H; Mehra P; Gupta S; Overcash JS; Porwal A; Giordano P; Lucasti C; Perez A; Good S; Jiang H; Moeck G; O'Riordan W;
N Engl J Med; 2014 Jun; 370(23):2180-90. PubMed ID: 24897083
[TBL] [Abstract][Full Text] [Related]
9. Adherence to oral antibiotic therapy in patients with bone and joint infection: A pilot study.
Lalande L; Bretagnolle C; Mabrut E; Ferry T; Goutelle S;
Infect Dis Now; 2021 Jun; 51(4):334-339. PubMed ID: 33975673
[TBL] [Abstract][Full Text] [Related]
10. Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT.
Knight M; Chiocchia V; Partlett C; Rivero-Arias O; Hua X; Bowler U; Gray J; Gray S; Hinshaw K; Khunda A; Moore P; Mottram L; Owino N; Pasupathy D; Sanders J; Sultan AH; Thakar R; Tuffnell D; Linsell L; Juszczak E
Health Technol Assess; 2019 Oct; 23(54):1-54. PubMed ID: 31590702
[TBL] [Abstract][Full Text] [Related]
11. Once-Daily Plazomicin for Complicated Urinary Tract Infections.
Wagenlehner FME; Cloutier DJ; Komirenko AS; Cebrik DS; Krause KM; Keepers TR; Connolly LE; Miller LG; Friedland I; Dwyer JP;
N Engl J Med; 2019 Feb; 380(8):729-740. PubMed ID: 30786187
[TBL] [Abstract][Full Text] [Related]
12. SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
File TM; Rewerska B; Vucinic-Mihailovic V; Gonong JRV; Das AF; Keedy K; Taylor D; Sheets A; Fernandes P; Oldach D; Jamieson BD
Clin Infect Dis; 2016 Oct; 63(8):1007-1016. PubMed ID: 27448679
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics for treating chronic osteomyelitis in adults.
Conterno LO; Turchi MD
Cochrane Database Syst Rev; 2013 Sep; (9):CD004439. PubMed ID: 24014191
[TBL] [Abstract][Full Text] [Related]
14. From 'OPAT' to 'COpAT': implications of the OVIVA study for ambulatory management of bone and joint infection.
Seaton RA; Ritchie ND; Robb F; Stewart L; White B; Vallance C
J Antimicrob Chemother; 2019 Aug; 74(8):2119-2121. PubMed ID: 30989175
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial.
Ibrahim LF; Hopper SM; Orsini F; Daley AJ; Babl FE; Bryant PA
Lancet Infect Dis; 2019 May; 19(5):477-486. PubMed ID: 30853250
[TBL] [Abstract][Full Text] [Related]
16. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.
von Dach E; Albrich WC; Brunel AS; Prendki V; Cuvelier C; Flury D; Gayet-Ageron A; Huttner B; Kohler P; Lemmenmeier E; McCallin S; Rossel A; Harbarth S; Kaiser L; Bochud PY; Huttner A
JAMA; 2020 Jun; 323(21):2160-2169. PubMed ID: 32484534
[TBL] [Abstract][Full Text] [Related]
17. Once-weekly dalbavancin versus daily conventional therapy for skin infection.
Boucher HW; Wilcox M; Talbot GH; Puttagunta S; Das AF; Dunne MW
N Engl J Med; 2014 Jun; 370(23):2169-79. PubMed ID: 24897082
[TBL] [Abstract][Full Text] [Related]
18. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH; Gerding DN; Poxton IR; Kelly C; Nathan R; Birch T; Cornely OA; Rahav G; Bouza E; Lee C; Jenkin G; Jensen W; Kim YS; Yoshida J; Gabryelski L; Pedley A; Eves K; Tipping R; Guris D; Kartsonis N; Dorr MB;
N Engl J Med; 2017 Jan; 376(4):305-317. PubMed ID: 28121498
[TBL] [Abstract][Full Text] [Related]
19. Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression.
Swindells S; Andrade-Villanueva JF; Richmond GJ; Rizzardini G; Baumgarten A; Masiá M; Latiff G; Pokrovsky V; Bredeek F; Smith G; Cahn P; Kim YS; Ford SL; Talarico CL; Patel P; Chounta V; Crauwels H; Parys W; Vanveggel S; Mrus J; Huang J; Harrington CM; Hudson KJ; Margolis DA; Smith KY; Williams PE; Spreen WR
N Engl J Med; 2020 Mar; 382(12):1112-1123. PubMed ID: 32130809
[TBL] [Abstract][Full Text] [Related]
20. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia.
Subedi S; Looke DF; McDougall DA; Sehu MM; Playford EG
Int J Infect Dis; 2015 Jan; 30():161-5. PubMed ID: 25603999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
